Agenus, Inc.

Agenus is a clinical-stage biopharmaceutical company that discovers, manufactures, and develops immunotherapies for cancer. Our portfolio consists of bio-engineered therapies designed to activate the body’s own defenses in order to fight cancer. These therapies are optimized through an integrated, proprietary active learning platform designed to deliver better drugs, optimized combinations, and predictive biomarkers to address critical unmet needs in cancer.